Search

Your search keyword '"Sloan, Andrew E."' showing total 29 results

Search Constraints

Start Over You searched for: Author "Sloan, Andrew E." Remove constraint Author: "Sloan, Andrew E." Publisher oxford university press (oup) Remove constraint Publisher: oxford university press (oup)
29 results on '"Sloan, Andrew E."'

Search Results

1. Detection of tumor-specific DNA methylation markers in the blood of patients with pituitary neuroendocrine tumors

2. Glioma stem cells activate platelets by plasma-independent thrombin production to promote glioblastoma tumorigenesis

3. Impact of race on care, readmissions, and survival for patients with glioblastoma: an analysis of the National Cancer Database

4. Multi-institutional noninvasive in vivo characterization of IDH, 1p/19q, and EGFRvIII in glioma using neuro-Cancer Imaging Phenomics Toolkit (neuro-CaPTk)

5. STEM-08. PLATELETS DRIVES GLIOBLASTOMA ONCOGENESIS BY ENHANCING THE GLIOMA STEM CELL PHENOTYPE

6. NIMG-66. AI-BASED PROGNOSTIC IMAGING BIOMARKERS FOR PRECISION NEUROONCOLOGY AND THE RESPOND CONSORTIUM

8. NCOG-33. HEMATOLOGIC PREDICTORS OF OUTCOMES IN GLIOBLASTOMA TREATED WITH SURGERY AND CHEMORADIATION

11. AI-based prognostic imaging biomarkers for precision neuro-oncology: the ReSPOND consortium

12. Proteins inform survival-based differences in patients with glioblastoma

14. Sex is an important prognostic factor for glioblastoma but not for nonglioblastoma

16. Germline rearrangements in families with strong family history of glioma and malignant melanoma, colon, and breast cancer

17. 372 Evolving Patterns in Clinical Utilization of Stereotactic Laser Ablation (SLA): An Analysis of the Multi-center Prospective Registry LAANTERN

18. 223 Procedural Safety of Stereotactic Laser Ablation (SLA) and Associated Hospital Stay: Outcome from the First Hundred Patient from LAANTERN Prospective Registry

20. Integrated genomic analysis of survival outliers in glioblastoma

21. An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825

26. Cancer Stem Cell-Specific Scavenger Receptor CD36 Drives Glioblastoma Progression

27. Heat-shock protein peptide complex–96 vaccination for recurrent glioblastoma: a phase II, single-arm trial

29. PTPμ suppresses glioma cell migration and dispersal

Catalog

Books, media, physical & digital resources